Search

  • HOME
  • Search
Information Desks
1090
2024 1형당뇨병 환자 지원을 위한 정책 개정
유재현
J Korean Diabetes. 2024;25(2):89-92.   Published online June 30, 2024
Focused Issues
글루카곤 수용체작용제의 기전 및 GLP-1/글루카곤/GIP수용체 삼중 효현제의 효과
민세희
J Korean Diabetes. 2024;25(2):82-88.   Published online June 30, 2024
1088
GLP-1/GIP수용체작용제: Tirzepatide의 작용기전을 중심으로
오태정
J Korean Diabetes. 2024;25(2):76-81.   Published online June 30, 2024
GLP-1수용체작용제
정승민
J Korean Diabetes. 2024;25(2):69-75.   Published online June 30, 2024
Statement
1형당뇨병과 2형당뇨병의 혈관합병증, 과연 같을까?
조윤경
J Korean Diabetes. 2024;25(2):62-68.   Published online June 30, 2024
Opinion
테크놀로지 혁신이 주도하는 당뇨병 진료환경의 변화
강신애
J Korean Diabetes. 2024;25(2):57-61.   Published online June 30, 2024
Information Desks
노인당뇨병 환자의 퇴원계획
조선희
J Korean Diabetes. 2024;25(1):52-56.   Published online March 31, 2024
1083
2023 당뇨병 식품교환표 개정과 식사계획을 위한 활용 지침
임정현
J Korean Diabetes. 2024;25(1):42-51.   Published online March 31, 2024
Focused Issues
1081
심혈관질환과 SGLT2억제제
박진주
J Korean Diabetes. 2024;25(1):26-34.   Published online March 31, 2024
1080
만성콩팥병과 SGLT2억제제
고은실, 정성진
J Korean Diabetes. 2024;25(1):16-25.   Published online March 31, 2024
1079
당뇨병과 SGLT2억제제: 지금까지의 여정과 향후 과제
김지윤, 김신곤
J Korean Diabetes. 2024;25(1):9-15.   Published online March 31, 2024
Statement
조기 발병 2형당뇨병, 그 관리전략
김진화
J Korean Diabetes. 2024;25(1):4-8.   Published online March 31, 2024
Opinion
Glucagon-Like Peptide-1수용체작용제의 전 세계적 품절 사태
이동원
J Korean Diabetes. 2024;25(1):1-3.   Published online March 31, 2024
Information Desks
1075
심리적 인슐린저항성 극복을 위한 동기면담 활용하기
임성철
J Korean Diabetes. 2023;24(4):227-231.   Published online December 31, 2023
1074
당뇨병과 비영양감미료
이지성
J Korean Diabetes. 2023;24(4):221-226.   Published online December 31, 2023

The Journal of
Korean Diabetes

Print ISSN: 2233-7431
Online ISSN: 2714-0547

  • 5,452 Clinical Nutrition Therapy for Weight Control in Obese Diabetic Patients
    4,838 Revisiting the Diabetes Crisis in Korea: Call for Urgent Action
    1,506 Technological Innovations Transforming Diabetes Care in Practice
    1,411 Mechanisms of Glucagon Receptor Agonism and GLP-1/Glucagon/GIP Receptor Triple Agonism for Treatment of Diabetes and Obesity
    1,279 A Young Adult’s Life with Diabetes Based on a Social Ecological Model

    +more

    • KoreaMed
    • KoMCI
    • GoogleScholar
    • Similarity Check
    • Crossref Cited-by Linking
    • CrossMark
    • Funder Registry
    • ORCID


Editorial Office
101-2104, Lotte Castle President, 109 Mapo-daero, Mapo-gu, Seoul 04146, Korea​
Tel: +82-2-714-9064    Fax: +82-2-714-9084    E-mail: diabetes@kams.or.kr                

Copyright © 2024 by Korean Diabetes Association. All rights reserved.

Developed in M2PI

Close layer